Literature DB >> 33963445

Variants in GCNA, X-linked germ-cell genome integrity gene, identified in men with primary spermatogenic failure.

Jimmaline J Hardy1, Margot J Wyrwoll2, William Mcfadden1, Agnieszka Malcher3, Nadja Rotte2, Nijole C Pollock1, Sarah Munyoki1, Maria V Veroli1, Brendan J Houston4, Miguel J Xavier5, Laura Kasak6, Margus Punab7,8, Maris Laan6, Sabine Kliesch9, Peter Schlegel10, Thomas Jaffe11, Kathleen Hwang12, Josip Vukina12, Miguel A Brieño-Enríquez1, Kyle Orwig1, Judith Yanowitz1, Michael Buszczak13, Joris A Veltman5, Manon Oud14, Liina Nagirnaja15, Marta Olszewska3, Moira K O'Bryan4, Donald F Conrad15, Maciej Kurpisz16, Frank Tüttelmann17, Alexander N Yatsenko18.   

Abstract

Male infertility impacts millions of couples yet, the etiology of primary infertility remains largely unknown. A critical element of successful spermatogenesis is maintenance of genome integrity. Here, we present a genomic study of spermatogenic failure (SPGF). Our initial analysis (n = 176) did not reveal known gene-candidates but identified a potentially significant single-nucleotide variant (SNV) in X-linked germ-cell nuclear antigen (GCNA). Together with a larger follow-up study (n = 2049), 7 likely clinically relevant GCNA variants were identified. GCNA is critical for genome integrity in male meiosis and knockout models exhibit impaired spermatogenesis and infertility. Single-cell RNA-seq and immunohistochemistry confirm human GCNA expression from spermatogonia to elongated spermatids. Five identified SNVs were located in key functional regions, including N-terminal SUMO-interacting motif and C-terminal Spartan-like protease domain. Notably, variant p.Ala115ProfsTer7 results in an early frameshift, while Spartan-like domain missense variants p.Ser659Trp and p.Arg664Cys change conserved residues, likely affecting 3D structure. For variants within GCNA's intrinsically disordered region, we performed computational modeling for consensus motifs. Two SNVs were predicted to impact the structure of these consensus motifs. All identified variants have an extremely low minor allele frequency in the general population and 6 of 7 were not detected in > 5000 biological fathers. Considering evidence from animal models, germ-cell-specific expression, 3D modeling, and computational predictions for SNVs, we propose that identified GCNA variants disrupt structure and function of the respective protein domains, ultimately arresting germ-cell division. To our knowledge, this is the first study implicating GCNA, a key genome integrity factor, in human male infertility.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33963445      PMCID: PMC8266742          DOI: 10.1007/s00439-021-02287-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   5.881


  53 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  Combining evidence using p-values: application to sequence homology searches.

Authors:  T L Bailey; M Gribskov
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

3.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

4.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

5.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

6.  SUMOylation promotes protective responses to DNA-protein crosslinks.

Authors:  Nikoline Borgermann; Leena Ackermann; Petra Schwertman; Ivo A Hendriks; Karen Thijssen; Julio Cy Liu; Hannes Lans; Michael L Nielsen; Niels Mailand
Journal:  EMBO J       Date:  2019-03-26       Impact factor: 11.598

7.  A systematic review and standardized clinical validity assessment of male infertility genes.

Authors:  Manon S Oud; Ludmila Volozonoka; Roos M Smits; Lisenka E L M Vissers; Liliana Ramos; Joris A Veltman
Journal:  Hum Reprod       Date:  2019-05-01       Impact factor: 6.918

Review 8.  Disease gene discovery in male infertility: past, present and future.

Authors:  M J Xavier; A Salas-Huetos; M S Oud; K I Aston; J A Veltman
Journal:  Hum Genet       Date:  2020-07-07       Impact factor: 4.132

9.  GCNA Interacts with Spartan and Topoisomerase II to Regulate Genome Stability.

Authors:  Gregoriy A Dokshin; Gregory M Davis; Ashley D Sawle; Matthew D Eldridge; Peter K Nicholls; Taylin E Gourley; Katherine A Romer; Luke W Molesworth; Hannah R Tatnell; Ahmet R Ozturk; Dirk G de Rooij; Gregory J Hannon; David C Page; Craig C Mello; Michelle A Carmell
Journal:  Dev Cell       Date:  2019-12-12       Impact factor: 12.270

10.  A genomics approach to male infertility.

Authors:  Hamed Alali; Mirna Assoum; Naif Alhathal; Sateesh Maddirevula; Serdar Coskun; Thomas Morris; Hesham A Deek; Soha A Hamed; Shaheed Alsuhaibani; Abdulmalik Mirdawi; Nour Ewida; Mashael Al-Qahtani; Niema Ibrahim; Firdous Abdulwahab; Waleed Altaweel; Majed J Dasouki; Abdullah Assiri; Wafa Qabbaj; Fowzan S Alkuraya
Journal:  Genet Med       Date:  2020-07-28       Impact factor: 8.822

View more
  6 in total

1.  Pathogenic variations in Germ Cell Nuclear Acidic Peptidase (GCNA) are associated with human male infertility.

Authors:  Maram Arafat; Sandra E Kleiman; Ali AbuMadighem; Atif Zeadna; Eliahu Levitas; Iris Har Vardi; Shimi Barda; Ofer Lehavi; Ron Hauser; Eitan Lunenfeld; Mahmoud Huleihel; Moran Gershoni; Ruti Parvari
Journal:  Eur J Hum Genet       Date:  2021-08-20       Impact factor: 4.246

2.  Genomic testing for copy number and single nucleotide variants in spermatogenic failure.

Authors:  J Hardy; N Pollock; T Gingrich; P Sweet; A Ramesh; J Kuong; A Basar; H Jiang; K Hwang; J Vukina; T Jaffe; M Olszewska; M Kurpisz; A N Yatsenko
Journal:  J Assist Reprod Genet       Date:  2022-07-18       Impact factor: 3.357

3.  Large-scale analyses of the X chromosome in 2,354 infertile men discover recurrently affected genes associated with spermatogenic failure.

Authors:  Antoni Riera-Escamilla; Matthias Vockel; Liina Nagirnaja; Miguel J Xavier; Albert Carbonell; Daniel Moreno-Mendoza; Marc Pybus; Ginevra Farnetani; Viktoria Rosta; Francesca Cioppi; Corinna Friedrich; Manon S Oud; Godfried W van der Heijden; Armin Soave; Thorsten Diemer; Elisabet Ars; Josvany Sánchez-Curbelo; Sabine Kliesch; Moira K O'Bryan; Eduard Ruiz-Castañe; Fernando Azorín; Joris A Veltman; Kenneth I Aston; Donald F Conrad; Frank Tüttelmann; Csilla Krausz
Journal:  Am J Hum Genet       Date:  2022-07-08       Impact factor: 11.043

4.  Whole-exome sequencing improves the diagnosis and care of men with non-obstructive azoospermia.

Authors:  Zine-Eddine Kherraf; Caroline Cazin; Amine Bouker; Selima Fourati Ben Mustapha; Sylviane Hennebicq; Amandine Septier; Charles Coutton; Laure Raymond; Marc Nouchy; Nicolas Thierry-Mieg; Raoudha Zouari; Christophe Arnoult; Pierre F Ray
Journal:  Am J Hum Genet       Date:  2022-02-15       Impact factor: 11.043

Review 5.  Proteolysis in Reproduction: Lessons From Gene-Modified Organism Studies.

Authors:  Daiji Kiyozumi; Masahito Ikawa
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

6.  Human Spermatogenesis: Insights From the Clinical Care of Men With Infertility.

Authors:  Peter N Schlegel
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-18       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.